Clinical Trials
The James Cancer Center Columbus, OHopen for enrollment
Safety, PKs, PDs, and Preliminary Efficacy PLX2853 Subjects w/Relap or Refrac AML or Myelodysplastic
Protocol: OSU-18314
Full Title
A Phase 1b Dose-escalation Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of PLX2853 in Subjects with Relapsed or Refractory Acute Myeloid Leukemia or High-risk Myelodysplastic Syndrome
Phase I Study
For More Information
See Full Trial at ClinicalTrials.gov